Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Celldex Therapeutics Inc

CLDX
Current price
43.76 USD -0.04 USD (-0.09%)
Last closed 43.47 USD
ISIN US15117B2025
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 739 666 688 USD
Yield for 12 month +54.57 %
1Y
3Y
5Y
10Y
15Y
CLDX
21.11.2021 - 28.11.2021

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey. Address: Perryville III Building, Hampton, NJ, United States, 08827

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

67 USD

P/E ratio

Dividend Yield

Current Year

+6 883 000 USD

Last Year

+2 357 000 USD

Current Quarter

+2 498 000 USD

Last Quarter

+156 000 USD

Current Year

+3 875 000 USD

Last Year

+957 000 USD

Current Quarter

+1 701 000 USD

Last Quarter

-619 000 USD

Key Figures CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -160 192 992 USD
Operating Margin TTM -1854.16 %
PE Ratio
Return On Assets TTM -17.83 %
PEG Ratio
Return On Equity TTM -27.53 %
Wall Street Target Price 67 USD
Revenue TTM 8 303 000 USD
Book Value 12.28 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 832.1 %
Dividend Yield
Gross Profit TTM -79 901 000 USD
Earnings per share -2.75 USD
Diluted Eps TTM -2.75 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CLDX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 11.02.2019
Dividend Date 11.02.2019

Stock Valuation CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 233.6185
Price Sales TTM 329.9611
Enterprise Value EBITDA -17.3415
Price Book MRQ 3.3671

Financials CLDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CLDX

For 52 weeks

22.11 USD 53.18 USD
50 Day MA 36.93 USD
Shares Short Prior Month 8 397 023
200 Day MA 37.82 USD
Short Ratio 11.39
Shares Short 8 661 767
Short Percent 15.12 %

Dynamics of changes in the value of assets

6

600329

27.97 CNY Tianjin Zhongxin Pharmaceutical Group Corp Ltd -0.04 (-0.92%)
Detailed analytics
P

PD2

18.70 EUR Patterson Companies Inc -0.11 (-0.53%)
Detailed analytics
1

14L

3.32 EUR A2 Milk Company Ltd 0 (0%)
Detailed analytics
U

UZD

22.93 USD United States Cellular Corporat -0.08 (-0.35%)
Detailed analytics
U

UZE

21.12 USD United States Cellular Preferred 5.500% due 2070 -0.04 (-0.19%)
Detailed analytics